Terms: = Prostate cancer AND CREB1, ENSG00000118260, 1385 AND Clinical Outcome
1 results:
1. ASCL1-mediated ferroptosis resistance enhances the progress of castration-resistant prostate cancer to neurosecretory prostate cancer.
Nie J; Zhang P; Liang C; Yu Y; Wang X
Free Radic Biol Med; 2023 Aug; 205():318-331. PubMed ID: 37355053
[TBL] [Abstract] [Full Text] [Related]